It was suggested that miR-15b-5p modulates platelet reactivity by targeting SUMO Specific Peptidase 5 (SENP5), a SUMO isopeptidase that is activated in the context of platelet activation, ischemia–reperfusion injury and cardiomyopathy [30, 31]. This evidence concerns the gene SENP5 and cardiomyopathy.